targetedonc.com Overview
Alexa Rank
454,435
Daily Pageviews per Visitor
1.5
Daily Time on Site
2:16
Bounce Rate
74.2%
Search Traffic
73.3%
Total Sites Linking In
328
Traffic Statistics
Audience Geography
| Visitors by Country | Site Traffic |
|---|---|
|
United States |
33.3% |
| Rankings by Country | Alexa Rank # |
|---|---|
|
United States |
132,038 |
Keyword Analysis
Top Keywords
| Top Keywords | Search Traffic |
|---|---|
|
osimertinib |
1.38% |
|
acalabrutinib |
1.15% |
|
targeted oncology |
1.03% |
|
adenocarcinoma stage 4 |
0.92% |
|
breast cancer immunotherapy |
0.79% |
Audience Report
Audience Overlap
Similar sites that share the same visitors and search keywords with this site.
| Similar Sites | Alexa Rank |
|---|---|
| 258,372 | |
| 240,305 | |
| 291,952 | |
| 90,708 | |
| 172,230 |
Social Engagement
| Websites | Total Articles | Engagement |
|---|---|---|
| 11,242 | 8 | |
| 6,912 | 7 | |
| 5,196 | 7 | |
| 1,205 | 37 | |
| 343 | 19 |
| Topic | Total Articles | Engagement |
|---|---|---|
|
clinical trials |
1,702 | 9 |
|
oncology |
2,469 | 8 |
|
patients |
3,590 | 8 |
Keyword Opportunities
Keyword Gaps
| Keyword | Competitors Traffic |
Search Popularity |
|---|---|---|
|
asco gi 2018 |
35 | 7 |
|
er metastatic breast cancer |
33 | 11 |
|
er metastatic breast cancer treatment |
31 | 8 |
|
asco 2021 |
30 | 17 |
These keywords are driving traffic to competitors, but not to this site.
Easy-to-Rank Keywords
| Keyword | Relevance to this site |
Search Popularity |
|---|---|---|
|
keynote 024 |
56 | 14 |
|
poziotinib |
59 | 21 |
|
alk inhibitor |
58 | 15 |
|
duvelisib |
59 | 27 |
These are popular keywords within this site's competitive power.
Buyer Keywords
| Keyword | Competitors Traffic |
Organic Competition |
|---|---|---|
|
metastatic breast cancer good news |
32 | 60 |
|
best of asco 2018 |
27 | 10 |
|
parp inhibitor comparison |
26 | 14 |
|
niraparib vs olaparib |
25 | 48 |
These keywords show a high purchase intent.
Optimization Opportunities
| Keyword | Search Popularity |
Organic Share of Voice |
|---|---|---|
|
luspatercept thalassemia |
13 | 4.22% |
|
undifferentiated pleomorphic sarcoma |
23 | 1.77% |
|
abemaciclib |
30 | 1.2% |
|
asco 2018 |
38 | 0.4% |
These are very popular keywords that are already driving some traffic to this site.
Competitive Analysis
| Websites | Search Traffic |
|---|---|
| 73.3% | |
| 65.4% | |
| 48.4% | |
| 40% | |
| 33.8% |
| Website | Referral Sites |
|---|---|
| 3.5 k | |
| 850 | |
| 611 | |
| 328 | |
| 92 |
Copyright © 2024 AlreadyCoded